Biopharma companies can help healthcare providers and specialist physicians stay abreast of scientific and medical information. Sej Brar describes what it takes to reshape and transform the strategic relevance of the medical affairs function. Related Practice Life Sciences & Pharma
Organization & Performance Published Articles How Not If: Remote Working and the ‘Next Normal’ May 18, 2020 In this article we review a range of potential remote working operating models and summarise our analytical framework for quantifying and assessing how…
Life Sciences & Pharma Executive Insights CAR-T: Unlocking Barriers to Adoption in Europe June 23, 2020 L.E.K. Consulting reviews progress to date, outlines barriers to uptake and identifies potential catalysts for accelerating European CAR-T adoption.
Organization & Performance Executive Insights Agile Transformation Part 1: Unlocking the Benefits of Agile May 6, 2020 Executives and leadership teams are looking to agile as a methodology for driving organisational transformation, and as a strategy to address three…
Strategy Presentations Global Situation Report Insights: Edition 2 June 9, 2020 The L.E.K. Global Situation Report is a uniquely rich, current, and customisable collection of indicators that provide a powerful recovery planning aide.
Healthcare Services Presentations Election 2020: The Next Phase of the US Healthcare Policy War October 19, 2020 The results of this study are reflective of news as of October 19, 2020. Overview of key policies and additional details on overall feasibility by…
Life Sciences & Pharma Presentations European Disease Progression Monitor: Edition 3 April 14, 2020 Weekly focus – A consistent pattern of lockdown exit strategies is emerging, with an initial focus on reopening childcare and small retail businesses.
